TABLE 3.
Deregulated miRNAs considering both adjacent to tumor and gastric cancer tissues.
| miRNA | Role in GC* | GC vs. NC | ADJ vs. NC | GC vs. ADJ |
| miR-125b-5p | OncomiR1,2 | Up | Up | – |
| miR-125b-1-3p | OncomiR1,2 | Up | Up | - |
| miR-218-1-3p | TS-miR3,4,5,6 | Up | Up | - |
| miR-490-3p | TS-miR7,8,9 | Up | Up | – |
| miR-200a-3p | TS-miR10 | Down | Down | – |
| miR-873-5p | TS-miR11,12 | Down | Down | – |
| miR-493-5p | TS-miR13 | Down | Up | – |
GC, gastric cancer; ADJ, adjacent to cancer; NC, non-cancerous; Up, up-regulated; Down, down-regulated; TS-miR, tumor suppressor miRNA; OncomiR, oncogenic miRNA. (-) Not differentially expressed. (*) Putative role in GC. (1) Wu et al., 2015; (2) Zhang et al., 2017b; (3) Deng et al., 2017; (4) Tang et al., 2016; (5) Zhang et al., 2017a; (6) Wang et al., 2017; (7) Shen et al., 2015; (8) Qu et al., 2017; (9) Yu et al., 2019; (10) Cong et al., 2013; (11) Chen et al., 2016; (12) Cao et al., 2016; (13) Zhou et al., 2015.